BBNX
insider transactionsBeta Bionics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-44.6K
0 buy · 44.6K sell
Net value · 90d
-$556.2K
$0 in · $556.2K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
10
0 buy · 44.6K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Chief Commercial Officer · 10b5-1
$3.4K
275 sh · $12.31
Own -0%
-
Sell·S
Director · 10b5-1
$39.4K
2.8K sh · $14.00
Own -9%
-
Sell·S
Chief Medical Officer
$53.2K
4.2K sh · $12.61
Own -2%
-
Sell·S
Sean Saint KEY
President & CEO
$212.7K
16.9K sh · $12.61
Own -4%
-
Sell·S
Stephen Feider KEY
Chief Financial Officer
$84.2K
6.7K sh · $12.61
Own -4%
-
Sell·S
Chief Product Officer
$55.2K
4.4K sh · $12.61
Own -2%
-
Sell·S
Chief Commercial Officer
$67.2K
5.3K sh · $12.61
Own -4%
-
Sell·S
Director · 10b5-1
$11.2K
998 sh · $11.21
Own -4%
-
Grant·A
Director · 10b5-1
$0
17.0K sh
Own +128%
-
Sell·S
Director · 10b5-1
$19.9K
2.0K sh · $9.95
Own -13%
-
Grant·A
Director · 10b5-1
$0
17.0K sh
Own +148%
-
Sell·S
Director · 10b5-1
$9.9K
1.0K sh · $9.95
Own -8%
-
Grant·A
Director
$0
17.0K sh
Own +136%
-
Grant·A
Director
$0
17.0K sh
Own +111%
-
Grant·A
Director
$0
17.0K sh
Own +111%
-
Grant·A
Director
$0
17.0K sh
Own +103%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Mark Hopman 10b5-1 | Sell S | 275 | $3.4K |
| Jun 4, 2026 | Christy Jones 10b5-1 | Sell S | 2.8K | $39.4K |
| Jun 2, 2026 | Steven Jon Russell | Sell S | 4.2K | $53.2K |
| Jun 2, 2026 | Sean Saint KEY | Sell S | 16.9K | $212.7K |
| Jun 2, 2026 | Stephen Feider KEY | Sell S | 6.7K | $84.2K |
| Jun 2, 2026 | Mike Mensinger | Sell S | 4.4K | $55.2K |
| Jun 2, 2026 | Mark Hopman | Sell S | 5.3K | $67.2K |
| May 22, 2026 | Adam Lezack 10b5-1 | Sell S | 998 | $11.2K |
| May 21, 2026 | Christy Jones 10b5-1 | Grant A | 17.0K | $0 |
| May 21, 2026 | Christy Jones 10b5-1 | Sell S | 2.0K | $19.9K |
| May 21, 2026 | Adam Lezack 10b5-1 | Grant A | 17.0K | $0 |
| May 21, 2026 | Adam Lezack 10b5-1 | Sell S | 1.0K | $9.9K |
| May 21, 2026 | Maria Palasis | Grant A | 17.0K | $0 |
| May 21, 2026 | Danny L. Dearen | Grant A | 17.0K | $0 |
| May 21, 2026 | Sean Carney | Grant A | 17.0K | $0 |
| May 21, 2026 | Gerard J Michel | Grant A | 17.0K | $0 |
About BBNX insider trading
This page tracks insider transactions for Beta Bionics, Inc. (BBNX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.